[2] He is an honorary consultant paediatrician at John Radcliffe Hospital and the director of the Oxford Vaccine Group.
[3] He is the chief investigator on the University of Oxford COVID-19 Vaccine (ChAdOx-1 n-CoV-19) trials and has led research on vaccines for many life-threatening infectious diseases, including typhoid fever, Neisseria meningitidis, Haemophilus influenzae type b, streptococcus pneumoniae, pertussis, influenza, rabies, and Ebola.
Pollard was awarded the coveted James Spence Medal[6] by the Royal College of Paediatrics and Child Health (RCPCH) in 2022.
He attended Guy's Hospital Medical School graduating with a BSc in 1986,[8] and subsequently obtained an MBBS from the University of London (1989) at St Bartholomew's Hospital Medical School, where he was awarded the Wheelwright's Prize in Paediatrics (1988) and Honours Colours.
[9] In 2020, Pollard received the Oxford University Vice Chancellor's Innovation Award[9][19] for his work on typhoid vaccines.